Early research (Phase 1)Study completedNCT00084643
What this trial is testing
GTI-2040, Oxaliplatin, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer or Other Solid Tumors
Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage IIIC Colon Cancer+6 more
National Cancer Institute (NCI) 20